Menu Search
Equities

Greenrise Global Brands Inc

C4T:FRA

Greenrise Global Brands Inc

Actions
  • Price (EUR)0.0046
  • Today's Change0.000 / 9.52%
  • Shares traded0.00
  • 1 Year change-97.70%
  • Beta--
Data delayed at least 15 minutes, as of Feb 03 2023 07:08 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Greenrise Global Brands Inc. is a Canada-based investment holding company with investments in the cannabis industry in Germany. The Company, through CannaCare Health GmbH (CannaCare), offers a range of approximately 20 cannabidiol (CBD) products consisting of tinctures, sprays and oils and skincare products made from natural raw materials manufactured in Europe and Germany and distributed through traditional sales channels, such as www.cannacare-health.com and www.canobo.de. CannaCare is a producer and supplier of CBD wellness products and wholly owns AMP Alternative Medical Products GmbH (AMP), an importer and distributor of European Union-Good Manufacturing Practice (EU-GMP) medical cannabis to pharmacies.

  • Revenue in CAD (TTM)784.63k
  • Net income in CAD-5.45m
  • Incorporated2013
  • Employees200.00
  • Location
    Greenrise Global Brands Inc224 5th Avenue WestVANCOUVER V5Y 1J4CanadaCAN
  • Phone+1 (604) 689-7565
  • Fax+1 (604) 683-9681
  • Websitehttps://greenriseglobal.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		 since
announced		Transaction
value
CannaCare Health GmbHAnnounced05 Apr 202205 Apr 2022Announced-72.22%3.31m
Data delayed at least 15 minutes, as of Jan 27 2023.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.